mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
NSC-207895 |
GDSC1000 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.2 |
mRNA |
IOX2 |
GDSC1000 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
BIX02189 |
GDSC1000 |
pan-cancer |
AAC |
-0.041 |
0.2 |